JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 53 filers reported holding JUNIPER PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 328,132 | $3,380,000 | 1.26% |
| Krensavage Asset Management, LLC | 288,326 | $2,970,000 | 0.95% |
| EAM Investors, LLC | 146,475 | $1,509,000 | 0.20% |
| ALGERT GLOBAL LLC | 37,017 | $381,000 | 0.18% |
| PERRITT CAPITAL MANAGEMENT INC | 73,000 | $752,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 174,064 | $1,793,000 | 0.09% |
| Bellevue Asset Management AG | 50,000 | $515,000 | 0.08% |
| Spark Investment Management LLC | 45,800 | $471,000 | 0.06% |
| CADENCE CAPITAL MANAGEMENT LLC | 82,392 | $849,000 | 0.06% |
| TFS CAPITAL LLC | 34,611 | $356,000 | 0.04% |